OXYMO TECHNOLOGIES INC.

General Information

Official company information

Registry ID: 9443177
Company Age: 9 years
Registration Date: 17 September 2015
Registered Address: 730 Rue Delage, Longueuil, QC J4G 2V8
Business Number (BN): 803482967RC0001
City: Beloeil
Status Notes: 2015-09-17
Email: N/A
Website: www.oxymotech.com/

Official company website with more information about products, services, and contact details.

About OXYMO TECHNOLOGIES INC.

Company profile and description

OXYMO Technologies, Inc. is a Canadian biotech company registered in Beloeil, Quebec, focusing on a groundbreaking antiviral therapeutic approach that directly targets HSV and Heparan Sulfate receptors. OXYMO is developing Oximo, a topical drug product for the treatment of oral and genital herpes. Oximo is scheduled to enter Phase I clinical trial in 2026 and Phase II trial in 2027.

Additional Information

Detailed company information and status

Version: 1808577365389869056
Hierarchy: parent
Entity Type: Business Corporation
Display Date: 2015-09-17
Jurisdiction: CC
Business Number: 803482967RC0001
MRAS Entity Type: BCA

Company Contacts

Key contacts and leadership 10 total contacts

Login For More

Name & Position	Email	Contact Number	Fax Number
P Pierre Attali, MD Chief Medical Officer	-	-	-
F Felix Furst President	-	-	-
O Olivier Chretien CEO and Co-Founder	-	-	-
F Françoise Marechal Director and Co-Founder	-	-	-
P Professor Remi Wilmotte Chemist and Co-Founder	-	-	-